Politicalpedia
Business

Diplomatic thaw in West Asia triggers a breakout rally for 47 stocks on the NSE

Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE

By Arjun MehtaPublished 12 June 2026· 2 min read
Diplomatic thaw in West Asia triggers a breakout rally for 47 stocks on the NSE
Diplomatic thaw in West Asia triggers a breakout rally for 47 stocks on the NSE

Indian markets surged on Friday as an unexpected US-Iran deal sparked a massive relief rally, pushing marquee names to yearly peaks.

The Indian equity markets witnessed a decisive shift in momentum this Friday, June 12, as the Nifty 50 and BSE Sensex posted gains exceeding 1%. The rally was broad-based, with 47 stocks on the National Stock Exchange (NSE) scaling fresh 52-week highs. Among the standout performers, Aegis Logistics, Cupid, Akums Drugs, and JB Chemicals led the charge, riding a wave of renewed investor optimism that swept through the trading floor by mid-afternoon.

The catalyst for this surge wasn't found in corporate earnings reports, but in the corridors of international diplomacy. Global markets reacted sharply to reports that the United States and Iran had reached a breakthrough, signing a Memorandum of Understanding to re-open the Strait of Hormuz and de-escalate long-standing oil sanctions. With Donald Trump confirming that military strikes had been cancelled and a formal agreement was imminent, the relief was palpable. Brent crude prices tumbled over 4%, falling to approximately $86.34 per barrel, providing a significant tailwind for the import-dependent Indian economy.

A flight to quality and growth

This uptick was not merely a reaction to external geopolitics; it underscored a growing appetite for specific sectoral plays. Aegis Logistics, which recently reported a robust 45% year-on-year jump in quarterly profit to ₹413 crore, saw its shares climb as investors cheered its strong financials and dividend announcement. Similarly, Akums Drugs and Pharmaceuticals has maintained a hot streak, recently outperforming its peers in the biotechnology space with consistent gains that have captured the attention of both retail and institutional traders.

The broader market surge also benefited from a strengthening rupee and cooling US bond yields, which eased the pressure on emerging market equities. As global risk sentiment shifted from defensive to growth-oriented, capital flooded into sectors ranging from logistics and pharma to banking and industrials. For investors, the session served as a stark reminder of how quickly macro-developments can recalibrate domestic valuations.

Why it matters: The bigger picture

This rally highlights the thin line between market volatility and opportunity. While the immediate trigger was the US-Iran diplomatic thaw, the underlying strength of the market is being driven by a search for resilient businesses that can weather geopolitical storms. Companies like JB Chemicals and Cupid are hitting highs because they demonstrate strong operational performance independent of global noise.

However, investors should remain cautious. Sharp, news-driven rallies often lead to profit-booking in subsequent sessions. While the easing of oil prices and the de-escalation in West Asia are undeniably positive for the Indian current account and inflation outlook, the sustainability of these 52-week highs will ultimately depend on whether these companies can translate current market euphoria into sustained quarterly growth. For now, the sentiment remains decisively bullish, provided the geopolitical calm holds.

By Arjun Mehta
National Affairs Correspondent

Arjun Mehta reports on government, policy and Parliament for PoliticalPedia, in English and Hindi.